甲胺磷预处理小菜蛾对菜蛾绒茧蜂的影响

分别在菜蛾绒茧蜂处于卵期、早期幼虫和中期幼虫时,饲喂小菜蛾2龄幼虫亚致死剂量甲胺磷,研究甲胺磷处理对寄主体内菜蛾绒茧蜂结茧率和羽化率的影响.试验表明,经亚致死剂量甲胺磷处理后,菜蛾绒茧蜂的结茧率和羽化率与对照相比均显著降低.在菜蛾绒茧蜂处于卵期时饲喂寄主幼虫,菜蛾绒茧蜂的结茧率和羽化率分别下降59.1%和32.5%;在菜蛾绒茧蜂处于早期幼虫时饲喂寄主幼虫,菜蛾绒茧蜂的结茧率和羽化率分别下降40.5%和32.8%;而在菜蛾绒茧蜂处于中期幼虫时饲喂寄主幼虫,菜蛾绒茧蜂的结茧率和羽化率分别下降18.2%和37.2%.结果表明,在绒茧蜂处于不同发育阶段时,饲喂小菜蛾幼虫甲胺磷对菜蛾绒茧蜂结茧率的影响较大,但对羽化率的影响不大.     

乳化剂对樱桃谷鸭生产性能、肌肉品质和脂类代谢的影响

将540只1日龄樱桃谷鸭随机分为3组,每组6个重复,每重复30只,分别饲喂添加0(对照组)、200、400 mg·kg-1乳化剂的试验日粮,试验期为42 d,研究不同含量乳化剂对樱桃谷鸭生长性能、肌肉品质和脂类代谢的影响.结果表明:添加400 mg·kg-1乳化剂可显著降低樱桃谷鸭前期料重比(P<0.05),提高42 d体重(P<0.05);添加200 mg·kg-1乳化剂可显著降低胸肌48 h滴水损失(P<0.05),提高胸肌24 h的pH(P<0.05).与对照组和200 mg·kg-1乳化剂组相比,添加400 mg·kg-1乳化剂可显著提高血清中的甘油三酯(TG)含量(P<0.05).添加200 mg·kg-1乳化剂可显著降低血清中的低密度脂蛋白胆固醇(LDL-C)含量(P<0.05),添加乳化剂对血清中的高密度脂蛋白胆固醇(HDL-C)、极低密度脂蛋白胆固醇(VLDL-C)和血清中的总胆固醇(TC)含量均无显著影响(P>0.05).结果提示,日粮中添加400 mg·kg-1乳化剂可提高樱桃谷鸭生产性能,添加200 mg·kg-1可改善胸肌肌肉品质,添加不同含量乳化剂均能不同程度改善脂类代谢.     

旱雀麦秋季药剂茎叶处理防效试验

70%彪虎水分散粒剂3～4g/667m2,用药量对水30L/667m2,在秋季小麦播种后旱雀麦杂草3～4叶期进行茎叶喷雾处理,对小麦安全,杂草防除效果达90.00%以上,与对照比增产效果达70.00%以上。     

Pharmacokinetics of Enrofloxacin and Its Metabolite Ciprofloxacin after Intramuscular Administration of Enrofloxacin in Goats

The pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin were investigated in goats after a single intramuscular administration of enrofloxacin at 2.5 mg/kg body weight. The plasma concentrations of enrofloxacin and ciprofloxacin were determined simultaneously by a HPLC method. The peak concentrations (C _max) of enrofloxacin (1.13 g/ml) and ciprofloxacin (0.24 g/ml) were observed at 0.8 and 1.2 h, respectively. The elimination half-life (t _1/2), volume of distribution (V _d(area)), total body clearance (Cl_B) and mean residence time (MRT) of enrofloxacin were 0.74 h, 1.42 L/kg, 1329 ml/h per kg and 1.54 h, respectively. The t _1/2, area under the plasma concentration–time curve (AUC) and the MRT of ciprofloxacin were 1.38 h, 0.74 g h/ml and 2.73 h, respectively. The metabolic conversion of enrofloxacin to ciprofloxacin was appreciable (36%) and the sum of the plasma concentrations of enrofloxacin and ciprofloxacin was maintained at or above 0.1 g/ml for up to 4 h. Enrofloxacin appears to be useful for the treatment of goat diseases associated with pathogens sensitive to this drug.     

Pharmacokinetics and Dosage Regimen of Enrofloxacin in Buffalo Bulls after Intramuscular Administration

The disposition kinetics and dosage regimen of enrofloxacin were investigated in breeding buffalo bulls following a single intramuscular administration of 5 mg/kg. The absorption half-life, half-life of the terminal phase, apparent volume of distribution and total body clearance were 0.262±0.099 h, 1.97±0.23 h, 0.61±0.13 L/kg and 210.2±18.6 ml/(kg.h), respectively. Therapeutic plasma levels (1 g/ml) were maintained for up to 6 h. A satisfactory intramuscular dosage regimen for enrofloxacin in buffalo bulls would be 8.5 mg/kg followed by 8.0 mg/kg at 8 h intervals.     

The effects of low doses of Senna occidentalis seeds on broiler chickens

The effects of 0.5%, 0.3% and 0.1% w/w concentrations of Senna occidentalis (So) seed mixed with commercial ration were studied in 18 groups of 32 broiler chicks each, from 1 day to 49 days of age. Three groups were fed one of the rations throughout their lives (TL). Three other groups were fed one of the rations from the 1st to the 28th day of life (starter phase, SP), and the final 3 groups were fed one of the rations from the 29th to 49th day (finisher phase, FP). Each experimental group was matched by a control group fed the same diet over the same period but without the inclusion of So. All the animals were killed at 49 days of age, and blood was collected from 10 birds in each group for biochemical studies (ALT, AST, GGT, LDH, UA). A complete necropsy was performed on 3 birds from each group. No significant differences in the biochemical parameters in the serum were found between the control and experimental chicks, but animals treated with 0.5% So in groups FP and TL, gained less weight and chicks that received 0.3% So or 0.5% So in the ration throughout life (TL) had a larger feed conversion ratio. Besides this, degenerative changes were found in the striated skeletal muscle in the chest, in the myocardium and in the liver in the animals that received the higher concentrations of So seeds.     

Disposition kinetics and dosage regimen of levofloxacin on concomitant administration with paracetamol in crossbred calves

The disposition kinetics of levofloxacin was investigated in six male crossbred calves following single intravenous administration, at a dose of 4 mg/kg body weight, into the jugular vein subsequent to a single intramuscular injection of paracetamol (50 mg/kg). At 1 min after the injection of levofloxacin, the concentration of levofloxacin in plasma was 17.2 ± 0.36 µg/ml, which rapidly declined to 6.39 ± 0.16 µg/ml at 10 min. The drug level above the MIC₉₀ in plasma, was detected for up to 10 h. Levofloxacin was rapidly distributed from blood to the tissue compartment as evidenced by the high values of the distribution coefficient, α (17.3 ± 1.65 /h) and the ratio of K₁₂/K₂₁ (1.83 ± 0.12). The values of AUC and Vd_area were 12.7 ± 0.12 µg.h/ml and 0.63 ± 0.01 l/kg. The high ratio of the AUC/MIC (126.9 ± 1.18) obtained in this study indicated the excellent antibacterial activity of levofloxacin in calves. The elimination half-life, MRT and total body clearance were 1.38 ± 0.01 h, 1.88 ± 0.01 h and 0.32 ± 0.003 l/kg/h, respectively. Based on the pharmacokinetic parameters, an appropriate intravenous dosage regimen for levofloxacin would be 5 mg/kg repeated at 24 h intervals when prescribed with paracetamol in calves.     

Subcutaneous pharmacokinetics and dosage regimen of cefotaxime in buffalo calves (Bubalus bubalis)

The pharmacokinetics and dosage regimen of cefotaxime following its single subcutaneous administration (10 mg/kg) were investigated in buffalo calves. Plasma and urine samples were collected over 10 and 24 h post administration, respectively. Cefotaxime in plasma and urine was estimated by microbiological assay technique using E. coli as test organism. The pharmacokinetic profiles fitted one-compartment open model. The peak plasma levels of cefotaxime were 6.48 ± 0.52 µg/ml at 30 min and the drug was detected upto 10 h. The absorption half-life and elimination half-life were 0.173 ± 0.033 h and 1.77 ± 0.02 h, respectively. The apparent volume of distribution and total body clearance were 1.17 ± 0.10 l/kg and 0.45 ± 0.03 l/kg/h, respectively. The urinary excretion of cefotaxime in 24 h, was 5.36 ± 1.19 percent of total administrated dose. A satisfactory subcutaneous dosage regimen for cefotaxime in buffalo calves would be 13 mg/kg repeated at 12 h intervals.     

星型环氧乳化剂合成及乳液的性能研究

采用自制星型乳化荆合成水性环氧乳液，考察了乳化剂的结构与环氧乳液稳定性及涂膜性能的关系，优化了乳化荆在制备环氧乳液过程中的主要参数。研究结果表明：聚乙二醇和环氧树脂E-20中环氧基与羟基的物质的量比为1．5：1．0、聚乙二醇的相对分子质量为4000、乳化剂用量为10％时，制备的环氧乳液稳定性高、成膜性能优良。     

2.5%保得乳油对小麦蚜虫控制作用的研究

对不同剂量的2.5%保得乳油防治麦蚜的效果进行了评价。结果表明,2.5%保得乳油施用有效成分为7.50、6.25g/hm2时,其防效均极显著优于对照药剂处理的防效,持效期达7d以上,对小麦生长安全无害。